Sucampo Pharma (SCMP) Arbitration Date w/ Takeda Extended; Disappointed by Outcome

Article Stock Quotes (1) Comments (0)

Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) today announced that the International Court of Arbitration, International Chamber of Commerce (ICC) has notified the Company of a change in the anticipated date of the decision related to the Company’s demand for arbitration under the applicable provisions of the Collaboration and License Agreement with Takeda Pharmaceuticals Company Limited, or Takeda. The ICC has extended the date from June 29, 2012 to July 31, 2012. Sucampo does not know how long thereafter the proceedings will conclude.

Sucampo is disappointed by the extension of the deadline of the decision; however, the Company continues its substantial planning in anticipation of a favorable award. Through these efforts, we look forward to increasing patient and healthcare provider access to Amitiza in the event of a favorable outcome.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• OSI Systems (OSIS) Unit Issued Notice of Proposed Debarment from U.S. DHS
• Medtronic (MDT) Receives CE Mark for Export Advance Catheter
• Paulson in Favor of Amended Plains Exploration (PXP), Freeport (FCX) Merger

Create E-mail Alert Related Categories

Corporate News, Litigation

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?